Experienced in HNRNPH2-Related Disorder

Dr. Craig A. Erickson

Child and Adolescent Psychiatry | Psychiatry | Pediatrics
Cincinatti Children's
Children's Hospital Medical Center
3333 Burnet Ave, 
Cincinnati, OH 
Accepting New Patients
Offers Telehealth

Experienced in HNRNPH2-Related Disorder
Cincinatti Children's
Children's Hospital Medical Center
3333 Burnet Ave, 
Cincinnati, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Craig Erickson is a Child and Adolescent Psychiatrist and a Psychiatrist in Cincinnati, Ohio. Dr. Erickson is rated as an Experienced provider by MediFind in the treatment of HNRNPH2-Related Disorder. His top areas of expertise are Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Aphantasia, and HNRNPH2-Related Disorder. Dr. Erickson is currently accepting new patients.

His clinical research consists of co-authoring 172 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Child and Adolescent Psychiatry
Psychiatry
Pediatrics
Licenses
Psychiatry & Neurology in IN
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

CHILDREN'S HOSPITAL MEDICAL CENTER
3333 Burnet Ave, Cincinnati, OH 45229
Call: 513-636-4200

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children, Adolescents and Young Adults With Fragile X Syndrome - RECONNECT
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children, Adolescents and Young Adults With Fragile X Syndrome - RECONNECT
Enrollment Status: Active_not_recruiting
Publish Date: May 25, 2025
Intervention Type: Drug
Study Drug: ZYN002
Study Phase: Phase 3
Randomized, Double-blind, Placebo-controlled, 28-Day Daily-dose Crossover Study of the Safety and Tolerability of SB-121 (Lactobacillus Reuteri With Sephadex® and Maltose) in Subjects, Ages 15 to 45 Years, Diagnosed With Autistic Disorder
Randomized, Double-blind, Placebo-controlled, 28-Day Daily-dose Crossover Study of the Safety and Tolerability of SB-121 (Lactobacillus Reuteri With Sephadex® and Maltose) in Subjects, Ages 15 to 45 Years, Diagnosed With Autistic Disorder
Enrollment Status: Completed
Publish Date: March 25, 2024
Intervention Type: Drug
Study Drug: SB-121
Study Phase: Phase 1
Effects of AFQ056 on Language Learning in Young Children With Fragile X Syndrome (FXS)
Effects of AFQ056 on Language Learning in Young Children With Fragile X Syndrome (FXS)
Enrollment Status: Completed
Publish Date: October 10, 2023
Intervention Type: Other, Drug
Study Drug: AFQ056
Study Phase: Phase 2
An Initial Double-Blind, Placebo-Controlled Two-Dose Crossover Study of AZD7325 in Adults With Fragile X Syndrome
An Initial Double-Blind, Placebo-Controlled Two-Dose Crossover Study of AZD7325 in Adults With Fragile X Syndrome
Enrollment Status: Completed
Publish Date: February 08, 2021
Intervention Type: Drug
Study Phase: Phase 1
Double-Blind Placebo-Controlled Study of Acamprosate in Autism
Double-Blind Placebo-Controlled Study of Acamprosate in Autism
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 1
Double-Blind, Placebo-Controlled Proof of Concept Study in Youth With Fragile X Syndrome
Double-Blind, Placebo-Controlled Proof of Concept Study in Youth With Fragile X Syndrome
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 1
Comparison of the Pharmacodynamic and Tolerability Profiles of Minocycline Versus Placebo in Autism Spectrum Disorder: a Double-blind, Placebo-controlled, Crossover, Proof-of-concept Study
Comparison of the Pharmacodynamic and Tolerability Profiles of Minocycline Versus Placebo in Autism Spectrum Disorder: a Double-blind, Placebo-controlled, Crossover, Proof-of-concept Study
Enrollment Status: Completed
Publish Date: December 08, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 6 Less Clinical Trials

172 Total Publications

Divergent aperiodic slope and alpha dynamics expose cortical excitability gradients in fragile X syndrome.
Divergent aperiodic slope and alpha dynamics expose cortical excitability gradients in fragile X syndrome.
Journal: Molecular autism
Published: July 25, 2025
View All 172 Publications
Similar Doctors
Advanced in HNRNPH2-Related Disorder
Dr. Amelle G. Shillington
Medical Genetics | Pediatrics
Advanced in HNRNPH2-Related Disorder
Dr. Amelle G. Shillington
Medical Genetics | Pediatrics

Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Amelle Shillington is a Medical Genetics specialist and a Pediatrics provider in Cincinnati, Ohio. Dr. Shillington is rated as an Advanced provider by MediFind in the treatment of HNRNPH2-Related Disorder. Her top areas of expertise are Chromosome 13q Deletion, Van Maldergem Syndrome, Polysyndactyly Cardiac Malformation, and Bardet-Biedl Syndrome. Dr. Shillington is currently accepting new patients.

Advanced in HNRNPH2-Related Disorder
Dr. Robert Hopkin
Medical Genetics | Pediatrics
Advanced in HNRNPH2-Related Disorder
Dr. Robert Hopkin
Medical Genetics | Pediatrics

Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4200
Languages Spoken:
English
See accepted insurances

Robert Hopkin is a Medical Genetics specialist and a Pediatrics provider in Cincinnati, Ohio. Dr. Hopkin is rated as an Elite provider by MediFind in the treatment of HNRNPH2-Related Disorder. His top areas of expertise are Fabry Disease, Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Micrognathia, and Orchiectomy.

Experienced in HNRNPH2-Related Disorder
Dr. Brian P. Kurtz
Child and Adolescent Psychiatry | Psychiatry
Experienced in HNRNPH2-Related Disorder
Dr. Brian P. Kurtz
Child and Adolescent Psychiatry | Psychiatry
3333 Burnet Ave, Ml 3014, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4788
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Brian Kurtz is a Child and Adolescent Psychiatrist and a Psychiatrist in Cincinnati, Ohio. Dr. Kurtz is rated as an Experienced provider by MediFind in the treatment of HNRNPH2-Related Disorder. His top areas of expertise are Autism Spectrum Disorder, HNRNPH2-Related Disorder, Oppositional Defiant Disorder (ODD), and Attention Deficit Hyperactivity Disorder (ADHD). Dr. Kurtz is currently accepting new patients.

VIEW MORE HNRNPH2-RELATED DISORDER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Erickson's expertise for a condition
ConditionClose
  • Elite
  • Autism Spectrum Disorder
    Dr. Erickson is
    Elite
    . Learn about Autism Spectrum Disorder.
    See more Autism Spectrum Disorder experts
    • Advanced
    • Attention Deficit Hyperactivity Disorder (ADHD)
      Dr. Erickson is
      Advanced
      . Learn about Attention Deficit Hyperactivity Disorder (ADHD).
      See more Attention Deficit Hyperactivity Disorder (ADHD) experts
    • Experienced
    • Alzheimer's Disease
      Dr. Erickson is
      Experienced
      . Learn about Alzheimer's Disease.
      See more Alzheimer's Disease experts
    • Anorexia
      Dr. Erickson is
      Experienced
      . Learn about Anorexia.
      See more Anorexia experts
    • Aphantasia
      Dr. Erickson is
      Experienced
      . Learn about Aphantasia.
      See more Aphantasia experts
    • Cyclic Vomiting Syndrome
      Dr. Erickson is
      Experienced
      . Learn about Cyclic Vomiting Syndrome.
      See more Cyclic Vomiting Syndrome experts
    • Delayed Growth
      Dr. Erickson is
      Experienced
      . Learn about Delayed Growth.
      See more Delayed Growth experts
    • Dementia
      Dr. Erickson is
      Experienced
      . Learn about Dementia.
      See more Dementia experts
    View All 12 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved